<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">27159</article-id><article-id pub-id-type="doi">10.7554/eLife.27159</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-86680"><name><surname>Cato</surname><given-names>Laura</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7072-4368</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86682"><name><surname>Neeb</surname><given-names>Antje</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86683"><name><surname>Sharp</surname><given-names>Adam</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86685"><name><surname>Buzón</surname><given-names>Victor</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77301"><name><surname>Ficarro</surname><given-names>Scott B</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86684"><name><surname>Yang</surname><given-names>Linxiao</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86687"><name><surname>Muhle-Goll</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86688"><name><surname>Kuznik</surname><given-names>Nane C</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86689"><name><surname>Riisnaes</surname><given-names>Ruth</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86690"><name><surname>Nava Rodrigues</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77492"><name><surname>Armant</surname><given-names>Olivier</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86694"><name><surname>Gourain</surname><given-names>Victor</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86695"><name><surname>Adelmant</surname><given-names>Guillaume</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86696"><name><surname>Ntim</surname><given-names>Emmanuel A</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49663"><name><surname>Westerling</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86697"><name><surname>Dolling</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86698"><name><surname>Rescigno</surname><given-names>Pasquale</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86714"><name><surname>Figueiredo</surname><given-names>Ines</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86715"><name><surname>Fauser</surname><given-names>Friedrich</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86716"><name><surname>Wu</surname><given-names>Jennifer</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-93274"><name><surname>Rottenberg</surname><given-names>Jaice T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86717"><name><surname>Shatkina</surname><given-names>Liubov</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86718"><name><surname>Ester</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86719"><name><surname>Luy</surname><given-names>Burkhard</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16315"><name><surname>Puchta</surname><given-names>Holger</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-93272"><name><surname>Troppmair</surname><given-names>Jakob</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-93273"><name><surname>Jung</surname><given-names>Nicole</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45612"><name><surname>Bräse</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-39661"><name><surname>Strähle</surname><given-names>Uwe</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77304"><name><surname>Marto</surname><given-names>Jarrod A</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86721"><name><surname>Nienhaus</surname><given-names>Gerd Ulrich</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5027-3192</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86722"><name><surname>Al-Lazikani</surname><given-names>Bissan</given-names></name><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-61884"><name><surname>Salvatella</surname><given-names>Xavier</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8371-4185</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-36010"><name><surname>de Bono</surname><given-names>Johann S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-86720"><name><surname>Cato</surname><given-names>Andrew CB</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8508-3834</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3615"><name><surname>Brown</surname><given-names>Myles</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8213-1658</contrib-id><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Medical Oncology</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Prostate Cancer Target Therapy Group</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">Sutton</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Institute for Research in Biomedicine</institution>, <institution>The Barcelona Institute of Science and Technology</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff><aff id="aff4"><institution content-type="dept">Blais Proteomics Center</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Institute of Applied Physics</institution>, <institution>Karlsruhe Institute of Technology</institution>, <addr-line><named-content content-type="city">Karlsruhe</named-content></addr-line>, <country>Germany</country></aff><aff id="aff6"><institution content-type="dept">Institute for Biological Interfaces 4</institution>, <institution>Karlsruhe Institute of Technology</institution>, <addr-line><named-content content-type="city">Karlsruhe</named-content></addr-line>, <country>Germany</country></aff><aff id="aff7"><institution content-type="dept">Institute of Toxicology and Genetics</institution>, <institution>Karlsruhe Institute of Technology</institution>, <addr-line><named-content content-type="city">Eggenstein-Leopoldshafen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff8"><institution content-type="dept">The Blais Proteomics Center</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Clinical Trials and Statistics Unit</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff10"><institution content-type="dept">Botanical Institute II</institution>, <institution>Karlsruhe Institute of Technology</institution>, <addr-line><named-content content-type="city">Karlsruhe</named-content></addr-line>, <country>Germany</country></aff><aff id="aff11"><institution content-type="dept">Institute for Biological Interfaces 4</institution>, <institution>Karlsruhe Institute of Technology</institution>, <addr-line><named-content content-type="city">Eggenstein-Leopoldshafen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff12"><institution content-type="dept">Daniel-Swarovski Research Laboratory, Department of Visceral, Transplant and Thoracic Surgery</institution>, <institution>Innsbruck Medical University</institution>, <addr-line><named-content content-type="city">Innsbruck</named-content></addr-line>, <country>Austria</country></aff><aff id="aff13"><institution content-type="dept">Institute of Organic Chemistry</institution>, <institution>Karlsruhe Institute of Technology</institution>, <addr-line><named-content content-type="city">Karlsruhe</named-content></addr-line>, <country>Germany</country></aff><aff id="aff14"><institution content-type="dept">Cancer Research UK Cancer Therapeutics Unit</institution>, <institution>The Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff15"><institution content-type="dept">Department of Medical Oncology</institution>, <institution>Dana-Farber Cancer Instittue</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1069"><name><surname>Dang</surname><given-names>Chi Van</given-names></name><role>Reviewing editor</role><aff><institution>University of Pennsylvania</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>andrew.cato@kit.edu</email> (AC);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>myles_brown@dfci.harvard.edu</email> (MB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>10</day><month>08</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e27159</elocation-id><history><date date-type="received"><day>23</day><month>03</month><year>2017</year></date><date date-type="accepted"><day>07</day><month>08</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Cato et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Cato et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-27159-v1.pdf"/><abstract><p>Targeting the activation function-1 (AF-1) domain located in the N-terminus of the androgen receptor (AR) is an attractive therapeutic alternative to the current approaches to inhibit AR action in prostate cancer (PCa). Here we show that the AR AF-1 is bound by the cochaperone Bag-1L. Mutations in the AR interaction domain or loss of Bag-1L abrogate AR signaling and reduce PCa growth. Clinically, Bag-1L protein levels increase with progression to castration-resistant PCa (CRPC) and high levels of Bag-1L in primary PCa associate with a reduced clinical benefit from abiraterone when these tumors progress. Intriguingly, residues in Bag-1L important for its interaction with the AR AF-1 are within a potentially druggable pocket, implicating Bag-1L as a potential therapeutic target in PCa.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000892</institution-id><institution>Prostate Cancer Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cato</surname><given-names>Laura</given-names></name><name><surname>Sharp</surname><given-names>Adam</given-names></name><name><surname>de Bono</surname><given-names>Johann S</given-names></name><name><surname>Cato</surname><given-names>Andrew CB</given-names></name><name><surname>Brown</surname><given-names>Myles</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005972</institution-id><institution>Deutsche Krebshilfe</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cato</surname><given-names>Andrew CB</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010627</institution-id><institution>Barr Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cato</surname><given-names>Laura</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000771</institution-id><institution>Prostate Cancer UK</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sharp</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sharp</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89939" source-id-type="uri"><collab>Cato L</collab>, <year>2017</year><x>,</x><source>Targeting the androgen receptor N-terminus via the  cochaperone Bag-1L</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89939">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89939</ext-link><x>,</x> <comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE89939)</comment></related-object></p></sec><supplementary-material><ext-link xlink:href="elife-27159-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>